ORLEANS, ON, Feb. 20, 2020 /CNW Telbec/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation“) (TSXV: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that a total of 31,292,471 common share purchase warrants (the “Warrants“) of the Corporation will be listed and
James E. Wagner Cultivation Reaches Supply Agreement with OCS and Prepares to Launch Products into Recreational Market
KITCHENER, Ontario, Feb. 19, 2020 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX: JWCA.V; OTCQX: JWCAF), has entered into a Master Cannabis Supply Agreement effective February 6, 2020, with the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). This
New licence allows for ongoing product development and the evaluation of cannabis concentrates in portable vaporizer devices for optimal formulations TORONTO, Feb. 13, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that
WAKEFIELD, Mass., Feb. 13, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”), a leading vertically integrated cannabis operator in the United States, today announced the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) has expired with respect to the acquisition of GR Companies, Inc.
WINNIPEG, Manitoba, Feb. 11, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX:DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has completed its final services milestone under an agreement with its Micro Cultivation partner Because You Cann Inc. (“Because
Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations TORONTO, Feb. 10, 2020 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is
WeedMD Subsidiary Starseed Medicinal Signs Innovative Benefits Provider myHSA to Medical Cannabis Program
Starseed and WeedMD become preferred medical cannabis suppliers to over 51,000 myHSA clients across Canada TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc.
SAN FRANCISCO and TEL AVIV, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) today announced that it has entered into a new agreement reached with the Salzman Group of Israel (the “Agreement”), under
Authorization from the Brazilian Health Regulatory Agency (ANVISA) allows for Khiron medical cannabis product to be imported for use on an individual patient basis Authorization follows December 2019 announcement by ANVISA allowing for a new class of medical cannabis-based product to be prescribed by doctors and sold